ABSTRACT
Activation of the activator protein 1 (AP-1) plays a critical role in oncogenesis by human T-cell leukemia virus type 1 (HTLV-1), the etiologic agent of adult T-cell leukemia (ATL), and is required for maintenance of the malignant phenotype. Curcumin (diferuloylmethane), the major pigment of the spice turmeric, has anti-tumor activity; however, the effect of curcumin against ATL has not been elucidated. In this study, we examined the effects of curcumin on AP-1 activity in HTLV-1-infected T-cell lines. Curcumin suppressed the constitutive AP-1 DNA-binding and transcriptional activity in HTLV-1-infected T-cell line. Curcumin also inhibited HTLV-1 Tax-induced AP-1 transcriptional activity. JunD was detectable as a major component of the AP-1-DNA complex in HTLV-1-infected T-cell lines using the supershift assay. The expression of JunD was suppressed by curcumin treatment. Curcumin inhibited the growth of HTLV-1-infected T-cell lines by inducing cell cycle arrest followed by apoptosis. Our results suggest that suppression of the constitutively active AP-1 by curcumin is due to, at least in-part, reducing the expression of JunD by curcumin. Inhibition of AP-1 activity by curcumin may be one of the mechanisms responsible for the anti-ATL effect of curcumin. We propose that curcumin is a potentially promising compound for the treatment of ATL.
Subject(s)
Curcumin/pharmacology , Enzyme Inhibitors/pharmacology , Human T-lymphotropic virus 1/metabolism , Leukemia-Lymphoma, Adult T-Cell/metabolism , Proto-Oncogene Proteins c-jun/antagonists & inhibitors , T-Lymphocytes/metabolism , Transcription Factor AP-1/metabolism , Apoptosis/drug effects , Cell Cycle/drug effects , Cell Line , Curcumin/therapeutic use , Enzyme Inhibitors/therapeutic use , Gene Expression Regulation, Leukemic/drug effects , Gene Expression Regulation, Viral/drug effects , Genes, pX/drug effects , Humans , Leukemia-Lymphoma, Adult T-Cell/drug therapy , Leukemia-Lymphoma, Adult T-Cell/pathology , Proto-Oncogene Proteins c-jun/metabolism , T-Lymphocytes/pathology , T-Lymphocytes/virology , Transcription, Genetic/drug effectsABSTRACT
In addition to malbranicin (1) and dihydromalbranicin (5), new substituted quinones 2, 3, 6 and hydroquinone 4 were isolated from the culture brothes of two strains of Malbranchea cinnamomea. The chemical constitutions of new metabolites 2, 3, 4 and 6 were elucidated by optical spectroscopy, mass spectrometry and 1D/2D NMR spectroscopy. 2 (7-methoxymalbranicin) at a concentration of 42 microM inhibited by 67% Tax/CREB-mediated expression of beta-galactosidase in a recombinant strain of Saccharomyces cerevisiae.
Subject(s)
Cyclic AMP Response Element-Binding Protein/drug effects , Genes, pX/drug effects , Hydroquinones/isolation & purification , Quinones/isolation & purification , Saccharomyces cerevisiae/drug effects , Hydroquinones/chemistry , Hydroquinones/pharmacology , Quinones/chemistry , Quinones/pharmacology , Saccharomyces cerevisiae/enzymology , Structure-Activity RelationshipSubject(s)
Anti-Retroviral Agents/therapeutic use , HIV Infections/drug therapy , HIV Infections/virology , HIV-1/isolation & purification , Anti-Retroviral Agents/pharmacology , Antiretroviral Therapy, Highly Active/methods , CD4 Antigens/blood , DNA, Complementary/drug effects , DNA, Viral/drug effects , Genes, pX/drug effects , HIV Infections/blood , Humans , RNA, Messenger/drug effects , Viremia/prevention & control , Viremia/virologyABSTRACT
HTLV-I is an exogenous human retrovirus that is a causative agent of adult T cell leukemia (ATL). In addition to the structural genes (gag, pol and env), a gene termed pX is postulated to be associated with leukemogenesis in ATL. Since no effective chemotherapy is currently available, it is important to find suitable therapeutic means against ATL. Here, we tested the inhibitory effect of antisense oligodeoxynucleotides (ODNs) on HTLV-I infection in different systems. ODNs were synthesized with the phosphorothioate backbone targeted to either structural genes or transactivator genes. The phosphorothioate ODNs were found to have two distinct target sites to exert their effect on HTLV-I infection: 1) Several ODNs, including sense ODNs and random oligomers, blocked syncytium formation induced by HTLV-I at a concentration of 0.1 microM. Their inhibitory effect on syncytium formation seemed to be exerted in a nonantisense manner, most probably due to their interaction with the cell membrane. 2) Efficient suppression by ODNs of gag gene expression after chemical induction was observed in HTLV-I-transformed T cells in an antisense manner. In this suppression, tax-antisense ODN showed virtually complete inhibition of gag protein expression, but not RNA expression, at the concentration of 0.1 microM, whereas tax-sense ODN displayed a weak inhibitory effect. Our results suggest that the influence of the phosphorothioate compound should be considered from the aspect of two separated mechanisms of antiviral activity, the effects on early (viral adsorption) and late (translation) phase infection.
Subject(s)
Genes, Viral/drug effects , Genes, pX/drug effects , Giant Cells/virology , Human T-lymphotropic virus 1/growth & development , Oligonucleotides, Antisense/pharmacology , Viral Structural Proteins/genetics , Virus Activation/drug effects , Animals , Gene Products, gag/antagonists & inhibitors , HTLV-I Antigens , Humans , Polymerase Chain Reaction , Rats , Retroviridae Proteins, Oncogenic/antagonists & inhibitors , Tumor Cells, Cultured , gag Gene Products, Human Immunodeficiency VirusABSTRACT
We have utilized antisense oligodeoxynucleotides (ODNs) to modulate transcriptional activation by the human T-cell leukemia virus type I (HTLV-I) tax gene, the major transcriptional regulator of this virus. 3'-Terminal phosphorothioate-modified antisense ODNs were shown to efficiently inhibit Tax protein expression both in vitro and in vivo. Terminal substitution did not affect the affinity of ODNs for their target sequence but conferred a 9-fold increase in tax inhibition in vitro. When delivered into mice by intraperitoneal injection, ODNs inhibited tax expression in established tumors by 90%. Unmanipulated tax-transformed mouse fibroblasts, or HTLV-I-transformed human lymphocytes, showed at least 5-fold higher ODN binding and uptake over control cells. Balb/3T3 cell binding was induced to similar levels by cellular activators. This suggests that constitutive activation by tax transformation may increase susceptibility of HTLV-I-transformed cells to antisense therapy, providing a rationale for the use of antisense ODN therapeutics in HTLV-I-associated diseases.